相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Hemoglobin Variability in Nondialysis Chronic Kidney Disease: Examining the Association with Mortality
Neil C. Boudville et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Hemoglobin Variability in Anemia of Chronic Kidney Disease
Kamyar Kalantar-Zadeh et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Hemoglobin is inversely related to flow-mediated dilatation in chronic kidney disease
Mahmut I. Yilmaz et al.
KIDNEY INTERNATIONAL (2009)
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
Marc A. Pfeffer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Model predictive control of erythropoietin administration in the anemia of ESRD
Adam E. Gaweda et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Association of Hemoglobin Variability and Mortality among Contemporary Incident Hemodialysis Patients
Steven M. Brunelli et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
History-adjusted marginal structural analysis of the association between hemoglobin variability and mortality among chronic hemodialysis patients
Steven M. Brunelli et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Hemoglobin level variability: Associations with mortality
David T. Gilbertson et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patients
Ryan D. Kilpatrick et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia
Charles L. Bennett et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes
Lynda A. Szczech et al.
KIDNEY INTERNATIONAL (2008)
Association between number of months below K/DOQI haemoglobin target and risk of hospitalization and death
Areef Ishani et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Hemoglobin variability and mortality in ESRD
Wei Yang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Functional data analysis applied to a randomized controlled clinical trial in hemodialysis patients describes the variability of patient responses in the control of renal anemia
Robert M. West et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis
Arintaya Phrommintikul et al.
LANCET (2007)
Target level for hemoglobin correction in patients with diabetes and CKD: Primary results of the anemia correction in diabetes (ACORD) study
Eberhard Ritz et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2007)
Correction of anemia with epoetin alfa in chronic kidney disease
Ajay K. Singh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Normalization of hemoglobin level in patients with chronic kidney disease and anemia
Tilman B. Drueke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Hemoglobin level variability: Associations with comorbidity, intercurrent events, and hospitalizations
James P. Ebben et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Impact of anemia on hospitalization and mortality in older adults
Bruce F. Culleton et al.
BLOOD (2006)
Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients
Deborah L. Regidor et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort - The cardiovascular health study
NA Zakai et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Type of vascular access and survival among incident hemodialysis patients: The choices for healthy outcomes in caring for ESRD (CHOICE) study
BC Astor et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Erythropoietin increases asymmetric dimethylarginine in endothelial cells:: Role of dimethylarginine dimethylaminohydrolase
F Scalera et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Vascular access and all-cause mortality: A propensity score analysis
KR Polkinghorne et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Epoetin requirements predict mortality in hemodialysis patients
Y Zhang et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
Administration of parenteral iron and mortality among hemodialysis patients
HI Feldman et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Protocolized anemia management with erythropoietin in hemodialysis patients: A randomized controlled trial
KS Brimble et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
The association of initial hemodialysis access type with mortality outcomes in elderly medicare ESRD patients
JL Xue et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
Type of vascular access and mortality in US hemodialysis patients
RK Dhingra et al.
KIDNEY INTERNATIONAL (2001)